Mirus Bio Achieves ISO 13485:2016 Certification: A Milestone in Quality Management
Mirus Bio, a renowned life sciences company, has recently marked a significant milestone by achieving the ISO 13485:2016 certification. This accomplishment underscores the company’s commitment to maintaining the highest quality standards in its operations, particularly in the development of innovative solutions for nucleic acid delivery, which are crucial in cell and gene therapy production, biopharmaceutical […]
Kytopen and Mirus Bio Announce Partnership to Unlock New and Scalable Genome Engineering Capabilities for the Next-Generation of Living Medicines
CAMBRIDGE, Mass., Jan. 31, 2023 /PRNewswire/ — Kytopen, a biotechnology company leading advancements in high-throughput cellular and genome engineering platforms, today announced a partnership with the pioneering transfection company, Mirus Bio, pairing their technologies to resolve challenges related to the delivery of complex genetic materials to living human cells. “Gene-modified cell therapies hold great promise for patients. […]